MARINUS PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 1646000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | MARINUS PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:06:28.339684+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2524f9c6-2c7e-4571-8a91-2b2730e2ef7b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-21-015263 · Open the official SEC filing →Retrieved: 2026-08-19T12:06:28.339684+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001267813/accounts-receivable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2524f9c6-2c7e-4571-8a91-2b2730e2ef7b
History
- no predecessors — first report